![]() |
||||||
|
||||||
|
|   Home |
|   Version française |
![]() |
|   Who is EMIL ? |
|   Presentation |
|   General Objectives |
|   Programme Activities |
![]() |
|   European Commission |
|   What is FP6 ? |
|   What is a NoE ? |
![]() |
|   Technological and Training Platforms |
|   Presentation |
|   Oligonucleotides and Peptides Imaging |
|
|
|   Gene Therapy Imaging |
|   Bioluminescent Imaging |
|   Cell and Animal Engineering |
|   Magnetic Resonance Imaging |
![]() |
|   Research Activities |
|   Presentation |
|   Molecular Imaging Technologies |
|   Molecular Imaging Probes |
|   Development of New Animal Models |
|   Bioluminescent Imaging and Multimodality Imaging |
|   Imaging & Follow-up of Guided Therapies |
|   Imaging for Drug Development |
|   Molecular Imaging of Apoptosis in Cancer |
![]() |
|   EMIL Partners |
|   Partner level 1 |
|   Partner level 2 |
|   Partner level 3 |
![]() |
| Trainings Activities |
![]() |
|   News & Events |
|   EMIL News & Events |
![]() |
| Contributors |
![]() |
| Publications |
![]() |
| Press Room |
![]() |
| Links |
![]() |
|   Job opportunities |
|   Post-docs |
|   Job candidates area |
![]() |
| Contact Us |
![]() |
| Internal Website |
| test |
|
|
![]() |
![]() |
![]() |
![]() |
| |||||||||||||||||||||||||||||
|
|
|